Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.81 -0.05 (-0.62%)
As of: Oct 23, 2026 · 3:58 PM EDT

Aspire Biopharma Holdings, Inc. (ASBP) Profit After Tax (2024 - 2026)

Updated

Aspire Biopharma Holdings' Profit After Tax was -$1.27 million in Q2 2026, compared with -$1.98 million a year earlier.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) Profit After Tax (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Aspire Biopharma Holdings' Profit After Tax was -$15.2 million through Jun 30, 2026; for FY2025, it came in at -$24.48 million.

  • In earlier years, Profit After Tax was -$1.31 million in FY2024 and -$358,108 in FY2023.
  • The Q2 2026 figure marks the highest quarterly Profit After Tax since Q4 2024.
  • Per Business Quant data, ASBP's Profit After Tax in the three quarters before Q2 2026 was -$3.22 million (Q1 2026), -$8.08 million (Q4 2025) and -$2.63 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.27 Mn
Mar 31, 2026 -3.22 Mn
Dec 31, 2025 -8.08 Mn
Sep 30, 2025 -2.63 Mn
Jun 30, 2025 -1.98 Mn
Mar 31, 2025 -15.94 Mn
Dec 31, 2024 -667,722.00
Sep 30, 2024 -216,269.00
API Access

Aspire Biopharma Holdings, Inc. Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=ASBP&period=max&api_key=YOUR_API_KEY